Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure
Shih‐Lin Chang(National Yang Ming Chiao Tung University), Shih-Ann Chen(Taipei Veterans General Hospital), Satoshi Higa(Tomishiro Central Hospital), Shuen-Hsin Liu(Taipei Medical University-Shuang Ho Hospital), Shien‐Fong Lin(National Yang Ming Chiao Tung University), Jo‐Nan Liao(L-3 Communications (United States)), Ta‐Chuan Tuan(National Yang Ming Chiao Tung University), Yu‐Feng Hu(Albert Einstein College of Medicine), Ya-Wen Hsiao(Taipei Veterans General Hospital), Li‐Wei Lo(National Yang Ming Chiao Tung University), Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Yu‐Cheng Hsieh(National Yang Ming Chiao Tung University), Yung-Nan Tsai(National Yang Ming Chiao Tung University), Fa‐Po Chung(L-3 Communications (United States)), Tsu-Juey Wu(National Yang Ming Chiao Tung University), Tze‐Fan Chao(National Yang Ming Chiao Tung University)
Cited by 91
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
Screening for Atrial Fibrillation
|Circulation|2017|535
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
|Thrombosis and Haemostasis|2021|476
Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
|Journal of the American College of Cardiology|2015|258
Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
|Circulation|2018|221